SCHEMBL19075307

SCHEMBL19075307

CC(C)(C)C(=O)OCn1ccc2c(-c3cnn(C(C)(CC=N)C4CCCC4)c3)ncnc21

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19928590 0.89 JAK2 (0.35) JAK2
SCHEMBL23220225 0.80 SIGMAR1 (0.41) JAK2
SCHEMBL19928587 0.79 JAK2 (0.31) JAK2
SCHEMBL21083833 0.78 KDM5B (0.39) —
SCHEMBL3006796 0.78 JAK2 (0.32) JAK2
SCHEMBL3005736 0.78 JAK1 (0.41) JAK2
SCHEMBL31330334 0.78 JAK1 (0.41) JAK2
SCHEMBL3006804 0.78 JAK2 (0.32) JAK2
SCHEMBL3006800 0.78 JAK2 (0.32) JAK2
SCHEMBL3005734 0.78 JAK1 (0.41) JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2398774-B1 PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS INCYTE HOLDINGS CORP (US) 2017-07-05 — — EP disclosed
Send feedback